Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

600 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Active, Not Recruiting

A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

NCT04971226

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists Pan Tallahassee, Florida, United States
  • University of Kentucky Lexington, Kentucky, United States
View all 110 locations
View Trial Details
Active, Not Recruiting

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

NCT04013685

Conditions
Acute Leukemia, Acute Lymphoid Leukemia, Acute Myeloid Leukemia, +31 more
Locations
  • City of Hope Duarte, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Stanford Health Care Stanford, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

NCT06092879

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Angers, France
  • Novartis Investigative Site Limoges, Haute Vienne, France
  • Novartis Investigative Site Saint Priest Jarez, Pays de la Loire Region, France
  • Novartis Investigative Site Aix-en-Provence, France
View all 52 locations
View Trial Details
Active, Not Recruiting

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

NCT02091245

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia (CML) in Blast Crisis, +26 more
Locations
  • UCSF San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

NCT05456191

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Illinois Cancer Care Peoria, Illinois, United States
  • Regions Hospital Saint Paul, Minnesota, United States
  • Messino Cancer Centers Asheville, North Carolina, United States
View all 120 locations
View Trial Details
Active, Not Recruiting

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

NCT04626024

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations
  • Baylor College of Medicine- McNair Campus Houston, Texas, United States
  • Ben Taub General Hospital Houston, Texas, United States
  • CHI St. Luke's Health Baylor College of Medicine Medical Center Houston, Texas, United States
  • Harris Health System- Smith Clinic Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

NCT03610971

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +13 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory -Winship Cancer Institute Atlanta, Georgia, United States
  • Memorial Sloan Kettering - Bergen Montvale, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details

Related conditions